Novavax (NVAX) IV at 133 into developing Covid-19 vaccine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/27/2026

1. NVDA
2. OKTA
3. CRM
4. CRWD
5. VEEV
6. P
7. KKR
8. HPQ
9. NTNX
10. SNPS

Go back to Novavax (NVAX) IV at 133 into developing Covid-19 vaccine
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.12 -0.09 (0.98%)
Previous Close $9.21    52 Week High $9.23 
Open $9.12    52 Week Low $1.16 
Day High $9.18    P/E N/A 
Day Low $8.92    EPS $-0.30 
Volume 1,857,364